2 Stocks Down 28% and 34% to Buy and Hold

TransMedics shares have fallen 28% over the past year as Q2 revenue growth slowed to 21% year over year to $189.9 million and adjusted EPS dropped 52% to $0.44, reflecting investment in kidney-transplant approval efforts and its logistics network. SoFi shares are down 34% despite Q2 revenue rising 43% to $1.2 billion and net income increasing 61% to $156.6 million; disappointing guidance, a previously elevated forward P/E above 45, and interest-rate uncertainty cloud the near term. The article argues both stocks offer longer-term upside through TransMedics' organ-transplant market expansion and SoFi's 35% member growth to 15.8 million and cross-selling opportunity.

Analysis

TMDX is transitioning from a high-margin device story toward an asset-intensive clinical-services/logistics model. The strategic upside is higher organ utilization and a larger revenue pool per transplant, but the market will not underwrite that optionality until management demonstrates that aviation, procurement, and staffing costs scale below revenue. The key 1-3 month catalyst is evidence of sequential gross-margin stabilization and utilization growth; absent that, the stock remains vulnerable to another de-rating as investors revise terminal-margin assumptions.

The more investable second-order angle is that a scaled proprietary logistics network could raise switching costs for transplant centers and pressure smaller organ-transport providers, but it also introduces execution and regulatory concentration risk. Kidney approval would expand the addressable market materially over 6-18 months, yet approval alone is insufficient: reimbursement, center adoption, and fleet capacity determine whether incremental revenue converts to FCF. Falsify a constructive view if adjusted operating margin continues to contract despite revenue growth, or if capital expenditure and working-capital needs prevent operating cash conversion.

SOFI's valuation is less a conventional bank multiple question than a proof-of-operating-leverage question. A lower-rate cycle can hurt loan yields initially, but it can also reduce funding costs, stimulate refinancing/origination demand, and improve platform activity; the net effect depends on deposit beta, credit performance, and whether cross-sell raises products per member without materially increasing acquisition expense. Over the next quarter, guidance credibility and credit-loss trends matter more than headline customer growth.

Consensus may be too quick to treat SOFI as rate-directional. If management sustains fee-based technology/platform growth and product penetration, the company can earn a higher multiple than regional banks; conversely, any deterioration in personal-loan delinquencies would expose that premium as fragile. TMDX has the stronger long-duration moat but a less defined near-term earnings floor; SOFI offers the cleaner tactical setup only after guidance is reset or credit data confirms resilience.

Key Decisions for Investors

• TMDX: remain on watch rather than initiate aggressively ahead of the next earnings print. Buy only on evidence of sequential gross-margin stabilization and reaffirmed kidney/logistics milestones; target a 6-18 month position sized for execution risk. Exit or avoid if operating-margin pressure persists alongside rising cash burn.
• SOFI: initiate a small 3-6 month long only after the next monthly/quarterly credit disclosures confirm stable personal-loan delinquencies and charge-offs. The upside is multiple re-expansion if funding costs fall and guidance is rebuilt; risk is asymmetric if credit losses force reserve additions or a guidance cut.
• Pair expression: long SOFI / short KRE over 3-6 months if deposit growth remains firm and fee revenue outgrows lending, isolating SOFI's digital distribution and cross-sell optionality from broad bank-rate exposure. Close if SOFI's credit metrics worsen relative to regional-bank consumer portfolios.
• Avoid using NVDA or NFLX as read-through trades; their inclusion is promotional and provides no fundamental linkage to either TMDX or SOFI.